# A Survey of Icatibant in Pediatric Participants With Hereditary Angioedema

> **NCT05509569** · — · COMPLETED · sponsor: **Takeda** · enrollment: 32 (actual)

## Conditions studied

- Hereditary Angioedema (HAE)

## Interventions

- **DRUG:** Icatibant

## Key facts

- **NCT ID:** NCT05509569
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-24
- **Primary completion:** 2025-10-31
- **Final completion:** 2025-10-31
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2025-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05509569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05509569, "A Survey of Icatibant in Pediatric Participants With Hereditary Angioedema". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05509569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*